Abrdn PLC Cytokinetics Inc Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Abrdn PLC holds 922,929 shares of CYTK stock, worth $32.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
922,929
Previous 602,421
53.2%
Holding current value
$32.5 Million
Previous $24.2 Million
25.95%
% of portfolio
0.05%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
394Shares Held
126MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$517 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$418 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$351 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$282 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$214 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.32B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...